BD MAX™ EXTENDED ENTERIC BACTERIAL PANEL. - COFEPRIS Registration 2374R2018 SSA
Access comprehensive regulatory information for BD MAX™ EXTENDED ENTERIC BACTERIAL PANEL. (BD MAX™ EXTENDED ENTERIC BACTERIAL PANEL.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2374R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on October 16, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PRUEBA DIAGNÓSTICA IN VITRO AUTOMATIZADA PARA LA DETECCIÓN CUALITATIVA DIRECTA Y LA DIFERENCIACIÓN DE PATÓGENOS BACTERIANOS ENTÉRICOS. EL PANEL DE BACTERIAS ENTÉRICAS AMPLIADO BD MAX DETECTA LOS ÁCIDOS NUCLEICOS DE: • PLESIOMONAS SHIGELLOIDES • VIBRIO
AUTOMATED IN VITRO DIAGNOSTIC TEST FOR DIRECT QUALITATIVE DETECTION AND DIFFERENTIATION OF ENTERIC BACTERIAL PATHOGENS. THE ENLARGED ENTERIC BACTERIA PANEL BD MAX DETECTS NUCLEIC ACIDS FROM: • PLESIOMONAS SHIGELLOIDES • VIBRIO